home / stock / miro / miro news

MIRO News and Press, Miromatrix Medical Inc. From 05/30/23

Stock Information
Company Name: Miromatrix Medical Inc.
Stock Symbol: MIRO
Market: NASDAQ
Website: miromatrix.com
Menu
MIRO MIRO Quote MIRO Short MIRO News MIRO Articles MIRO Message Board
Get MIRO Alerts

News, Short Squeeze, Breakout and More Instantly...
MIRO - Miromatrix Presenting at the 2023 American Transplant Congress

EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced it will be presenting at the upcoming 2023 America...
MIRO - Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference

EDEN PRAIRIE, Minn., May 30, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, announced that members of the management team will participa...

MIRO - Miromatrix Medical Inc. (MIRO) Q1 2023 Earnings Call Transcript

2023-05-14 04:25:21 ET Miromatrix Medical Inc. (MIRO) Q1 2023 Earnings Conference Call May 11, 2023 04.30 PM ET Company Participants Hannah Jeffrey - Gilmartin, Investor Relations Jeff Ross - Chief Executive Officer Jim Douglas - Chief Financial Officer Con...

MIRO - Miromatrix Medical GAAP EPS of -$0.33 misses by $0.04, revenue of $7.98M

2023-05-11 16:05:29 ET Miromatrix Medical press release ( NASDAQ: MIRO ): Q1 GAAP EPS of -$0.33 misses by $0.04 . Revenue of $7.98M (+17.9% Y/Y). For further details see: Miromatrix Medical GAAP EPS of -$0.33 misses by $0.04, revenue of $7.98M
MIRO - Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported first quarter 2023 financial results and prov...

MIRO - Miromatrix to Report First Quarter 2023 Financial Results

EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will report financ...

MIRO - Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med

EDEN PRAIRIE, Minn., April 10, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, announced that CEO Jeff Ross, Ph.D will present at ...
MIRO - CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation

CareDx Exclusive Provider of dd-cfDNA Testing Services for Use in Miromatrix Clinical Trials Companies at Forefront of Alternative Organ Supply Research to Address Organ Shortage BRISBANE, Calif. and EDEN PRAIRIE, Minn., April 05, 2023 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDN...

MIRO - Miromatrix Medical Inc. (MIRO) Q4 2022 Earnings Call Transcript

2023-03-31 21:38:08 ET Miromatrix Medical Inc. (MIRO) Q4 2022 Earnings Conference Call March 31, 2023 16:30 ET Company Participants Hannah Jeffrey - Investor Relations Jeff Ross - Chief Executive Officer Jim Douglas - Chief Financial Officer Conference Call...

MIRO - Miromatrix Medical GAAP EPS of -$0.33 beats by $0.06, revenue of $0.93M beats by $0.93M

2023-03-31 16:06:20 ET Miromatrix Medical press release ( NASDAQ: MIRO ): Q4 GAAP EPS of -$0.33 beats by $0.06 . Revenue of $0.93M (-88.4% Y/Y) beats by $0.93M . For further details see: Miromatrix Medical GAAP EPS of -$0.33 beats by $0.06, revenue of $0....
Previous 10 Next 10